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Objective:  To determine the knowledge and practice patterns of a UK cohort of relevant 
Health Care Professionals (HCP) about delivering palliative care in cirrhosis, and to inform 
priorities for future research. 
Design: An on-line questionnaire survey with closed and open responses.  
Setting: HCP identified from the mailing list of special interest groups in hepatology and 
gastroenterology (liver), general practice (GP) and specialist palliative care (SPC) across the 
UK. 
 
Results Of the 6181 potential contacts identified, 517 HCP responded. Most believed a role 
exists for SPC in caring for people with cirrhosis, but many SPC HCPs felt ill-prepared to 
provide good care to those facing death. Further training was needed in managing liver-
related symptoms, symptom control and end of life issues. All HCP groups wished to 
increase community provision of palliative care support, but many GPs felt unable to 
manage advanced cirrhosis in the community. There were differences in the optimal trigger 
for SPC referral with liver HCP less likely to refer at symptom deterioration. Prognostication, 
symptom management and service configuration were key areas identified for future 
research. 
 
Conclusions All who responded acknowledged both the role of SPC in caring for those dying 
with cirrhosis and needs for further training to improve confidence and enable joint working 
between SPC, GP and liver teams.  Low response rates make it difficult to generalise these 






   
ESLD survey paper v19 (2015 05 11) 3  
 
Introduction 
Liver disease is the third largest cause of premature death in the United Kingdom (UK) 1 and 
accounts for 2% of deaths in England2. The increases in alcohol consumption, viral hepatitis 
and obesity in the UK suggest that liver disease is a growing public health problem3. People 
with end stage liver disease (cirrhosis) have supportive and palliative care needs4-7. The 
recent Lancet Commission report on improving liver care acknowledges the importance of 
both primary care and hospital services in providing high quality care for people with 
cirrhosis1. Nevertheless it skims over the care issues arising for those who are dying of liver 
disease. At present, this care is poor8, most deaths from cirrhosis occur in hospital2 and 
more work is needed to understand how end of life (EoL) care for people with cirrhosis can 
be managed well.   
 
The Royal Free Hospital London (tertiary centre) liver team and the Marie Curie Palliative 
Care Research Department, University College London held a national meeting of health 
professionals interested in these aspects of liver care in November 2013.  The group 
recommended a national survey of primary, secondary and tertiary care providers to 
explore current attitudes and practices, and to identify training needs, ideas for service 




We developed an online survey (see Appendix ii – see Supplementary file) to explore a) 
referrals to specialist palliative care – numbers, reasons, timing; b) health professionals’ 
training needs; c) ideas for improved end of life care in cirrhosis; d) areas for future 
research.   
The link to the survey and an invitational e-mail were sent to (i) those working in liver 
teams; (ii) those working in specialist palliative care; (iii) General Practitioners (GP) with an 
interest in gastroenterology. To identify potential participants, we gained the co-operation 
of key professional organisations who contacted their members with two reminders at three 
week intervals (Appendix ii – see Supplementary file):  
1) Liver teams: a) the British Society for Gastroenterology (Liver section); b) the 
British Association for the Study of the Liver (Doctors and Nurses); c) the British 
Liver Trust Nurses Forum; d) Royal College of Nurses (Gastroenterology Forum) 
and e) the London Liver group. 
2) Specialist palliative care teams: a) Association of Palliative Medicine of Great 
Britain and Ireland; b) the National Nurse Consultant Group (Palliative Care); c) 
Clinical and nursing leads in specialist palliative care units (‘Help the Hospice’ 
database).  
3) General Practitioners: the Primary Care Society for Gastroenterology.   
We used descriptive statistics to explore data on responders’ demographics, referrals to 
specialist palliative care, training needs in caring for people with cirrhosis and key areas for 
research. Open-ended questions were analysed using frequency content analysis after 
which we triangulated quantitative data and open responses. Statistical analyses were 
conducted using Stata 139.  
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Research ethics approval was received from UCL Ethics committee (3552/002). 
 
Results 
A maximum of 6,181 contacts received the online survey and we received data from 514 
respondents: 195 liver professionals, 273 SPC and 46 GP professionals (response rates 4%, 
23% and 10% respectively; overall response rate 8%).  A breakdown of responders by 
speciality and discipline (see Appendix iii – see Supplementary file) showed that most were 
from a medical background (306/514) and worked in specialist palliative care (273/514). 
Analysis by NHS Region (see Appendix iv – see Supplementary file) showed responses across 
the UK, with most from the North of England.  
 
Provision of specialist palliative care (SPC)  
Referrals to SPC  
Nearly all SPC professionals (97%; 262/269) had accepted referrals from liver teams for 
patients with cirrhosis near the end of life; most (86%; 232/269) had been referred at least 
one patient during the last year. However, patients with cirrhosis made up a median 1% of 
SPC workload (IQR: 1-2, range: 0-20).  
Numbers of referrals reported by liver professionals (Table 1) to SPC were low; most 
referred fewer than 11 patients a year (Table 1) and these were more likely to be in-patients 
than out-patients (Table 1). Referrals from General Practice (GP) were equally low, with only 
19% (44/228) of SPC professionals receiving referrals for patients with cirrhosis, and no 
more than 5 patients per year.  
Insert Table 1  
Reasons for referrals to SPC, from liver professionals and GPs were symptom control, 
terminal care and the need for hospice admission (Table 2). Most liver and SPC professionals 
identified recognition of the end of life as the key trigger for SPC referral in cirrhosis. SPC 
professionals also considered onset of deterioration in symptoms and recurrent hospital 
admissions as appropriate triggers for referral to their service (Table 2). 
Insert Table 2  
 
End-of-life care for cirrhosis in primary care 
Over half of GPs (55%; 22/40) felt their patients could be managed in the community, but 
only 24% (10/41) had actually received a referral from liver centres. Confidence in managing 
patients in the community was attributed to good support from community nursing or local 
specialist palliative care teams. Barriers were the perceived unpredictable nature of 
cirrhosis and patients’ social circumstances (especially those actively drinking).  
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Skills levels and training needs  
Although most SPC professionals (60%; 147/246) and GPs (54%; 22/41) were confident in 
their skills and knowledge to manage people with cirrhosis, all recognised the need for 
further training on issues specific to liver disease; liver and GP professionals identified 
symptom control and training in end of life issues as the two key topics to address (Table 3).  
Open response data showed that liver professionals need improved awareness of 
supportive care including symptom control at EoL, advanced communication skills in 
discussing prognosis with patients and families, and help to shift the emphasis of care from 
an interventionist to a more supportive role; liver and GP personnel need improved 
knowledge on how SPC could support them to care for people with advanced cirrhosis and 
the processes of accessing community SPC.  
Liver professionals felt that both primary care and SPC needed specific training in 
understanding the unpredictable trajectory of cirrhosis and the impact of impaired liver 
function on medication metabolism.  SPC professionals recognised their training needs on 
liver specific issues such as the assessment and management of decompensated liver 
disease (86%; 198/231), pharmacology in cirrhosis (79%; 182/231), likely illness trajectory in 
cirrhosis (68%; 159/231), advances in the management of recurrent ascites (68%; 158/231) 
and information on prognostication (68%; 158/231). 
Insert Table 3  
 
Initiatives for improving EoL care in cirrhosis  
Liver professionals suggested enhanced provision of palliative care whereas most SPC 
professionals prioritised improved liaison between secondary and primary care. GPs also 
favoured improved liaison (33/39; 85%), more educational opportunities in specialist liver 
units (26/39; 67%) and improved provision of specialist palliative care (18/39; 46%).  
Analysis of open responses from 137/195 liver professionals (88 doctors and 49 nurses), 
identified specific and more detailed improvements which could be made to the delivery of 
EoL care, both in reconfiguring services and improving clinicians’ skill base.  
(i) Earlier SPC involvement: Significant time points in the patient journey, such as 
assessment for liver transplantation, repeated hospital admissions or onset of 
need for regular paracentesis could prompt SPC referral. Understanding of 
appropriate triggers and markers of deterioration may support health 
professionals to recognise when symptomatic patients would benefit from SPC 
which can be delivered in parallel with more aggressive treatments.   
(ii) Better community provision of liver services: Better liaison between liver teams, 
primary care and SPC could enable patients to receive community nursing and 
paracentesis, enhanced by hospice out-patient services to provide support and 
symptom control as required, which may reduce emergency admissions to 
hospital. 
(iii) Development of clearer care pathways: Understanding of care pathways would 
guide liver professionals to identify which patients with cirrhosis had reached the 
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EoL phase and what to do next. An EoL pathway would provide a framework to 
consider withdrawal of medication and opportunities for both patients and those 
close to them to access counselling and support.  
(iv) Ways of improving communication skills: Liver professionals recognised that 
patients and family members had little understanding about their disease or its 
severity. At the same time, they themselves lacked confidence in having honest 
discussions about these topics.  Sharing of information about the disease, its 
likely trajectory and symptoms might allow more open discussions about future 
care, and choices about place of care, interventions and services available.  
Key priorities for future research  
Open responses on research priorities were received from 221 participants. Table 4 
highlights the key findings.  (i) Disease specific information - all groups highlighted the need 
to understand:  symptom control (in particular how best to manage recurrent ascites, 
pruritus and encephalopathy, and opioid pharmacology when liver function is 
compromised), and prognostication (in particular identifying the earliest point when 
deterioration is irreversible);  (ii) Service models -both SPC and liver professionals prioritised 
exploring whether palliative care adds value (economical or quality of life), the best way of 
managing patients in the community to avoid hospital admissions, and the evaluation of an 
early palliative care intervention versus usual care; understanding would be enhanced by 
exploring the experience of both patient and their family members in (a) their 
understanding of prognosis and their own wishes about future preference of care (b) what 
specific needs they have as a result of the illness.  
 
Insert Table 4 here 
Discussion 
This is the first UK-based national survey on the perspectives of health professionals 
responsible for delivering care to people with cirrhosis who are facing death.  
Referrals from liver teams to specialist palliative care are relatively uncommon and usually 
made late in the illness when death is very close. Understanding of the role of specialist 
palliative care was poor. All health professionals, irrespective of speciality, recognised that 
they required further training to improve their skills in caring for people with advanced 
cirrhosis.  For SPC, this training centred on increasing awareness of specific issues involved 
in managing patients with liver disease, such as the implications of impaired liver function 
on symptom control and medication use. For liver professionals, future training should 
support them to identify patients for whom cure is no longer likely and to shift the emphasis 
of care from burdensome interventions to a more supportive care role.  All groups recognise 
the need for collaborative working earlier in the illness so that discussions about the future 
can be raised at key points such as transplant assessments or exacerbations of symptoms. 
We identify symptom management, prognostication, and overall service structure as key 
areas for future research.  
Our findings support key recommendations from a recent review of palliative care in end 
stage liver disease including better collaboration between liver health professionals and 
specialist palliative care and the identification of potential triggers for palliative care 
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consultations4.  Our work also supports recommendations from the Lancet Commission 
report on the role primary care in liver disease and the need for community hepatology 
posts for GPs to work more closely with liver professionals1.  
Lessons can be learned from research on the management of people with other advanced 
non-malignant diseases. In the UK, in advanced heart failure10 and advanced kidney 
disease11 shared care approaches have been developed involving multi-professional 
collaboration between primary care and specialist services, and specialist palliative care 
input when required.  The key elements are sensitive communication with patients and their 
families especially earlier in the illness, holistic assessment and care involving multi-
professional working across boundaries. While planning at a national level is not easy, on a 
local level, it would be important to improve education and coordination of service 
provision between liver specialists, general practice and specialist palliative care.      
We note the very low response rate to our survey, which currently limits the generalizability 
of our findings which require further validation. This low response rate may be due to 
limitations in our methods. Data Protection issues prevented us from accessing mailing lists 
directly, which was the responsibility of the special interest groups, so the delivery of the 
mail-out was inconsistent. E-mail circulations may have been incomplete, and overlap in the 
membership of our targets groups (e.g. BASL and the BSG liver section) may underestimate 
the response rate.  However, our highest response rate of 24% achieved from SPC is still 
lower than the 33%12 considered standard for on-line surveys.  It is possible, but we cannot 
be certain that there is currently a reluctance to consider issues of end of life care amongst 
those working with people with cirrhosis. However, it is likely that the potential benefits of a 
palliative approach to care, either early and in parallel to more aggressive treatments, or in 
managing the terminal phase are not yet recognised.  
Our response rates might have been higher had the research team been able to access 
directly the mailing list from each of the different organisations.  This would have enabled 
the research team to check for duplicate participants and personalise the invitation letter 
before sending out to each health professional.  We might also have been able to ensure 
that each non-responding professional received up to two follow-up e-mails to encourage 
their participation in the survey. Furthermore, if finances were available, we would have 
given participants on receipt of their response a non-monetary incentive such as Amazon 
gift cards to be used for educational purposes. Some of these initiatives have been 
identified in a Cochrane review as increasing response rates in electronic surveys13. 
    
Conclusion 
While there are plans to address the high mortality from liver disease, these initiatives will 
be slow to demonstrate any impact on mortality figures and many will continue to die with 
high symptom burden and little care planning at the end of life. The financial challenges 
faced by the NHS over the next years as outlined by the NHS England Chief Executive14 
confirm that we cannot expect significant financial support to address the problem. We 
recommend research that takes account of economic costs and benefits, and improves our 
understanding of the needs of patients with cirrhosis and their families, enhances 
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communication with those at risk of death, enables smoother links across care boundaries, 
and informs training for all professionals involved in treatments and care. 
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Table 1: The number of patients referred to specialist palliative care from liver 
professionals by type of care and diagnosis.  
 
Number referred by liver 
professionals to SPC 
Number of referrals 
received by SPC 
 
In-patient care Outpatient care 
Cirrhosis 
N % N % N % 
None 7 4 71 44 37 14 
1-5 45 28 51 32 158 59 
6-10 49 30 14 9 45 17 
11-20 38 24 16 10 25 9 
21+ 22 14 9 6 4 1 
Total 161  161  269  
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Table 2:  Referrals to SPC for cirrhosis: reasons and timings  
 







N % N % N % 
Reasons for referral to SPC by speciality 
 
     
 Symptom Control 137 88 12 75   
 End of life issues 138 89 12 75   
 Hospice/Palliative Care 123 79 9 56   
 Social/family 73 47 8 50   
 Bereavement support 39 25 3 19   
 Ethical decision making 11 7 2 13   
 Communicating difficult news 7 5 1 6   
 Other 3 2 2 13   
 Total 155  16    
Most appropriate times for referral to 
SPC by speciality 
    
  
 End-stage/end-of-life 158 89   223 91 
 Deterioration in symptoms 105 59   198 81 
 Recurrent hospital admissions 111 63   180 74 
 Consideration of referral to tertiary liver 
centre,  
         for example, for liver transplant 
assessment 
32 18   59 24 
 Initial diagnosis 12 7   21 9 
 Other 13    0  
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Table 3: Comparison of training needs and initiatives to improve end of life care for 
patients with cirrhosis by speciality     
 







N % N % N % 
Comparison of training needs of liver 
and GP professionals 
    
  
 Symptom Control 101 66 31 91   
 End of life issues 101 66 18 53   
 Ethical decision making 55 36 9 27   
 Bereavement counselling 52 34 7 21   
 Social/family 45 29 8 24   
 Communicating difficult news 40 26 8 24   
 Other 4 3 2 6   
 Total 154  34    
Initiatives that would improve end of 
life care for patients with cirrhosis by 
speciality     
    
  
 Improved liaison between secondary and 
primary care 
69 39   90 37 
 Improved provision of specialist palliative 
care 
86 48   64 26 
 More education opportunities in specialist 
liver units 
21 12   71 29 
 Other 3 2   20 8 
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Table 4: Research themes identified by discipline  






Disease-specific information     
Symptom management 59 35 6 100 
Prognosis 23 18 1 42 
Needs assessment 11 15  26 
Epidemiology 6   6 
Psycho-social impact 4   4 
Stakeholder understanding of liver 
disease 
2 1  3 
New treatments  3  3 
     
Service model approaches      
Optimal service structure 14 5 2 21 
Evaluating added value of 
palliative care 
8 5  13 
Barriers/improving access to SPC 8   8 
     
Education     
How to improve management of 
liver  patients  
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